← Leaderboards
David C Smith
University Of Michigan At Ann Arbor
$1,804,107
Attributed
$1,804,107
Total exposure
8
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $321.7K · FY2005–10$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
Funding mix
By agency
NIH$1,804,107 · 8
By mechanism
P30$1,173,298 · 1
R21$611,550 · 1
M01$19,259 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Michigan At Ann Arbor
Same institution · by research overlap
- Max S. Wicha$49,028,071
- Eric R. Fearon$27,558,344
- Gregory T Wolf$6,682,960
- Brian D. Ross$27,286,369
- Dean E. Brenner$31,108,993
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchClinical TrialsHuman SubjectMalignant NeoplasmsResearch PersonnelResourcesNeoplasm /Cancer ChemotherapyCooperative StudyDoctor Of PhilosophyEnsureAreaCancer CenterConduct Clinical TrialsCase Report FormCollaborationsClinical Trials DatabaseDesignDatabasesBiostatistics CoreClinical InvestigatorBiometryClinical Trials Data Monitoring CommitteesData CollectionCore Facility
Grant awards (16)
CLINICAL TRIAL OFFICE$321,700
P30 · FY2010 · CA · contact PI
CLINICAL TRIAL OFFICE$319,644
P30 · FY2009 · CA · contact PI
CLINICAL TRIAL OFFICE$177,318
P30 · FY2008 · CA · contact PI
CLINICAL TRIAL OFFICE$177,318
P30 · FY2007 · CA · contact PI
GEMCITABINE & PACLITAXEL FOR METASTATIC UROTHELIAL CANCER IN PTS AGE 70 OR OLDER$1,356
M01 · FY2007 · RR · contact PI
THE USE OF 11C-CHOLINE IN PET IMAGING FOR ADVANCED STAGE BLADDER CANCER$1,131
M01 · FY2007 · RR · contact PI
CLINICAL TRIAL OFFICE$177,318
P30 · FY2006 · CA · contact PI
THE USE OF 11C-CHOLINE IN PET IMAGING FOR ADVANCED STAGE BLADDER CANCER$5,109
M01 · FY2006 · RR · contact PI
GEMCITABINE & PACLITAXEL FOR METASTATIC UROTHELIAL CANCER IN PTS AGE 70 OR OLDER$4,599
M01 · FY2006 · RR · contact PI
GEMCITABINE &PACLITAXEL FOR METASTATIC UROTHELIAL CANCER IN PTS AGE 70 OR OLDER$3,602
M01 · FY2005 · RR
Gemcitabine &Paclitaxel for Metastatic Urothelial Cancer in Pts Age 70 or Older$3,050
M01 · FY2004 · RR
Phase II Trial of Tetrathiomolybdate in Prostate Cancer$305,775
R21 · FY2002 · CA
CPT 11 (IRINOTECAN) &ESTRAMUSTINE IN PROSTATE CANCER$0
M01 · FY2002 · RR
Phase II Trial of Tetrathiomolybdate in Prostate Cancer$305,775
R21 · FY2001 · CA
A PHARMACODYNAMIC STUDY OF LIAROZOLE IN PATIENTS WITH ADVANCED MALIGNANCIES$206
M01 · FY2000 · RR
CPT 11 (IRINOTECAN) &ESTRAMUSTINE IN PROSTATE CANCER$206
M01 · FY2000 · RR